ProShares UltraPro Short QQQ ETF is a 3x inverse-leveraged tool for amplifying Nasdaq-100 declines, not a long-term ...

Welcome to News Corp's Second Quarter Fiscal 2026 Earnings Conference Call. Today's conference is being recorded. Media will be allowed on a listen-only basis. At this time, I'd like to turn the ...

A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...

Midwest-rooted Central Bank offers an online application, which you can track via mobile app. But you’ll have to contact the bank for mortgage rates. Among the best when it comes to online convenience ...

Councillors in Port Hope would make $46,514 after the fall election, compared to $32,227 now. That’s an increase of 44 per cent. Damian Maggio, one of the consultants who spoke to council on the ...

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors ...

With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one ...

Practice smart by starting with easier problems to build confidence, recognizing common coding patterns, and managing your ...

Australian drug developer Biotron may have found a potential cure for Hepatitis C, after all patients who completed a trial of its lead antiviral drug emerged with undetectable levels of the virus.